EBIT at other companies
Other financials
Where this comes from
Calculated from Amneal Pharmaceuticals, Inc.’s reported figures.
The official record: Amneal Pharmaceuticals, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Amneal Pharmaceuticals, Inc.'s ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Amneal Pharmaceuticals, Inc.'s EBIT?
- Amneal Pharmaceuticals, Inc. (AMRX) reported EBIT of $141.77M in Q1 2026.
- How has Amneal Pharmaceuticals, Inc.'s EBIT changed year-over-year?
- Amneal Pharmaceuticals, Inc.'s EBIT increased by 41.3% year-over-year, from $100.35M to $141.77M.
- What is the long-term trend for Amneal Pharmaceuticals, Inc.'s EBIT?
- Over 4 years (2021 to 2025), Amneal Pharmaceuticals, Inc.'s EBIT has grown at a 26.7% compound annual growth rate (CAGR), from $152.72M to $394.1M.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.